Heartseed, a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for the treatment of heart failure...
AIM ImmunoTech, an immunopharmaceutical company focused on the development of immunological, viral and multiple cancer t...
NAGASE & CO., LTD. (NAGASE) and Osaka University have launched DDS Products Joint Development Research Cha...
Japan based Takeda Pharmaceutical Company will share with members of the United States Congress that it is initiating th...
Japan based Saki Corporation, an innovator in the field of automated optical and X-ray inspection equipment, announces t...
Japan based Takeda Pharmaceutical Company Limited has announced that it has entered into an agreement to divest a p...
UCB Japan Co., Ltd, and Daiichi Sankyo Company, Limited are pleased to announce that a supplemental application for VIMP...
Japan based Takeda Pharmaceutical Company Limited announced that it has acquired US based PvP Biologics, Inc. follo...
Japan based Eisai Co., Ltd. and FUJI YAKUHIN CO., LTD. have concluded a license agreement concerning dotinurad (ge...
Japanese multinational conglomerate holding company SoftBank Group led the new funding round for US based firm...
Japan based pharmaceutical firm Eisai announced that it has received the President’s Award at the 8th Technology M...
H3 Biomedicine, Inc. (H3), precision medicine research & development subsidiary of Eisai Co has announced the a...
The Biotechnology Innovation Organization (BIO) has announced, it is canceling the annual BIO Asia conference in Tokyo s...
Japan based BitOne Group Company Limited and IBO Telecom Company Limited, a Hong Kong-based subsidiary of IBO Techn...
Japan based Chugai Pharmaceutical has announced that the Ministry of Health, Labour and Welfare (MHLW) has des...
Tokyo Medical and Dental University (TMDU), ACT Genomics (Taipei, Taiwan), and ACTmed (Japan) launched a joint clinical ...
In a study recently published in Nature Communications, scientists at Japan based Okayama University describe ...
Foundation Medicine, Inc. and Chugai Pharmaceutical Co., Ltd. have entered into an agreement with the&nbs...
Japan based Nippon Shinyaku Co., LTD. has announced that Janssen Pharmaceutical K.K. and Nippon Shinyaku entered into a ...
Researchers at Japan based Kanazawa University report in the Journal of Thoracic Oncology a promising novel ap...
Japanese firm Chugai Pharmaceutical Co., Ltd. has announced that it has entered into an agreement with National Cancer C...
Japan based Santen Pharmaceutical Co., Ltd. and US based Verily, an Alphabet company, have announced the establishment o...
Japan based Sumitomo Dainippon Pharma Co., Ltd. and UK based Exscientia Ltd. have announced that a phase I clinical stud...
In a recent study researchers at Okayama University, Japan illustrate the potential of berberine, a herbal Chinese medic...
TransEnterix, Inc. a medical device company that is digitizing the interface between the surgeon and the patient to impr...
US based AgeX Therapeutics, a biotechnology company developing therapeutics for human aging and regeneration, announced ...
Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd. (Torii) have announced that JT has received manufacturing and mark...
Japanese firm Eisai Co., Ltd., has entered into a joint research and development agreement with Personal Genome Diagnost...
Japanese firm Eisai Co., Ltd has obtained the manufacturing and marketing approval in Japan for its in-house discovered ...
Sasakawa Health Foundation has announced the start of its first-ever social media campaign with organizations of persons...
Amgen, Astellas Pharma and Amgen Astellas BioPharma K.K. announced that on April 1, 2020, Amgen will purchase the 49% of...
Japanese firm Eisai Co., Ltd. has obtained the approvals of supplementary new drug applications in Japan for its in-hous...
Swiss firm Ferring Pharmaceuticals has announced that Propess® (dinoprostone) has been approved by the Minister...
POXEL, headquartered France, and with subsidiaries in Japan, is a biopharmaceutical company focused on the development o...
The Japanese Ministry of Health, Labor and Welfare (MHLW) has granted marketing authorization for darolutamide, under th...
Takeda Pharmaceutical Company Limited, headquartered in Japan, is a value-based research-driven biopharmaceutical leader...
Hitachi Chemical Advanced Therapeutics Solutions, LLC, a US subsidiary of Japanese firm Hitachi Chemical Co., Ltd....
PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease target...
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as share...
Japan based Astellas Pharma Inc. has successfully completed the previously announced acquisition of Audentes Therapeutic...
Japan based Astellas Pharma Inc. has announced that the Third Fermentation Building (provisional name) will be construct...
US based company Charles River has announced a multi-year drug discovery collaboration with Japanese firm Takeda Pharmac...
Japan based Astellas Pharma Inc., through its wholly-owned subsidiary Universal Cells, Inc. and Adaptimmune Therapeutics...
ASKA Pharmaceutical Co., Ltd. and KinoPharma, Inc., both based in Tokyo, announced that they have entered into...
apceth Biopharma GmbH, a subsidiary of Japan headquartered Hitachi Chemical Co., Ltd. and a leading company for the manu...
ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-...
Japan based Astellas Pharma Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved its supplem...
Japanses firm Chugai Pharmaceutical Co., Ltd. has announced that the Company entered into a global licensing agreem...
US based HUYA Bioscience International CEO & Executive Chair, Dr. Mireille Gillings announced the appointm...
Alma, a global innovator of Laser, Light-based, Radiofrequency, Plasma and Ultrasound solutions for the aesthetic and su...
French firm Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of canc...
US based aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of innovative medicines b...
Urovant Sciences, a subsidiary of Sumitomo Dainippon Pharma has announced that it has entered into a $300 million term l...
Kyoto University researchers have developed a new 'tumor-on-a-chip' device that can better mimic the environment inside ...
Eisai Co., Ltd. presented its latest information on its in-house discovered and developed eribulin mesylate (halich...
Daiichi Sankyo Company has announced that it has launched the antitumor agent bevacizumab BS for intravenous drip infusi...
PENTAX Medical continues its commitment to Endoscopic Ultrasound (EUS) as an indispensable part of its flexible endoscop...
Japan based Astellas Pharma Inc. and US headquartered Xyphos Biosciences, Inc. have announced that Astellas has acq...
Daiichi Sankyo and AstraZeneca have announced that the U.S. Food and Drug Administration (FDA) has approved ENHERTU®...
Gilead Sciences, Inc. and Eisai Co., Ltd. have announced that Gilead Sciences K.K. and Eisai have entered into an agreem...
Eisai has announced that the U.S. Food and Drug Administration (FDA) approved DAYVIGO™ (lemborexant) 5 mg and...
Japan based TOWA PHARMACEUTICAL CO., LTD. and Spain based pharma company ESTEVE have announced that TOWA will acquire 10...
US based Turnstone Biologics, a biotechnology company pioneering the development of engineered viral immunotherapies,&nb...
Astellas Pharma Inc. and Seattle Genetics, Inc. have announced that the U.S. Food and Drug Administration (FD...
Japan based PHC Corporation has announced it was taking a stake in KAKEHASHI Inc., based on a share purchase agreement w...
Japan Agency for Medical Research and Development (AMED) and Singapore’s Agency for Science, Technology and Resear...
Pfizer and Japan based Astellas Pharma have announced that the U.S. Food and Drug Administration (FDA) has approved a su...
PENTAX Medical, a division of the HOYA Group which is a global med-tech company based in Tokyo, Japan, has cleared CE ma...
AstraZeneca and Daiichi Sankyo Company presented positive detailed data from the global pivotal Phase II single-arm DEST...
Japan based Eisai Co., Ltd. has had a groundbreaking ceremony for a major renovation of its Tsukuba Research Laboratorie...
FUJIFILM Toyama Chemical has announced the construction completion of a new manufacturing facility (facil...
Japan based Solasia Pharma K.K. has announced that it has entered into an exclusive license agreement with Maruho Co., L...
Enzyre based in The Netherlands, which is developing breakthrough ambulant diagnostic technology for coagulation testing...
Japan based Takeda Pharmaceutical Company Limited announced the presentation of the results of tourmaline-AL1 trial in a...
Japan headquartered Hitachi, Ltd. has entered into an agreement to provide Centro Nazionale di Adroterapia Oncologica (C...
bitBiome, Inc., a start-up company from Waseda University in Japan, and National Cancer Center of Japan&n...
Japan headquartered Astellas Pharma Inc. and Audentes Therapeutics, Inc. have entered into a definitive agreement for As...
Chugai Pharmaceutical has announced that the "New England Journal of Medicine" (NEJM) online edition November 27 R...
Japan based Fujitsu Laboratories Ltd. and Aichi Cancer Center (ACC) have successfully concluded a comprehensive cooperat...
Japan based Ono Pharmaceutical Co., Ltd. has announced that ONO submitted an application of tirabrutinib hydrochloride (...
Intravenous Infusion Monotherapy Dosage and Schedule in Japan Ono Pharmaceutical Co., Ltd. has announced that ONO submit...
Hitachi, Ltd. headquartered in Tokyo, Japan, is focusing on Social Innovation Business combining its operational technol...
US based Ardelyx, Inc., a specialized biopharmaceutical company focused on developing first-in-class medicines to improv...
US based Woolsey Pharmaceuticals has announced that it has completed a license agreement with Japanese pharmaceutical co...
Eisai Inc., the U.S. subsidiary of Eisai Co., Ltd., has announced the launch of Ella the Jellyfish, the first Amaz...
Japan based Shionogi & Co., Ltd. has announced the U.S. Food and Drug Administration (FDA) has approved FETROJA®...
Tokyo headquartered Eisai Co., Ltd. announced that it has launched the Equfina® 50mg TABLETS (safinamide mesila...
Japan headquartered Astellas Pharma Inc. and US based Welldoc, Inc. have entered into a collaboration and license agreem...
Merck, a leading science and technology company, has announced that the Japanese Ministry of Health, Labour and Welfare ...
Japan headquartered Toray Industries, Inc., has made an agreement with the Japan International Cooperation Agency (JICA)...
Sandoz has announced that it has entered into a binding agreement for the planned acquisition of the Japanese business o...
Indian pharma major Lupin Limited (including its subsidiaries, together referred to as ‘Lupin’) a...
Cancer Intelligence Care Systems, Inc. (CICS) and STELLA PHARMA CORPORATION will commence a Phase I clinical trial of Bo...
Japan headquartered Takeda Pharmaceutical Company Limited recentky hosted an R&D meeting in New York City to ou...
Japan based NEC Corporation, a leader in IT and network technologies, and VAXIMM AG, a Swiss/German biotech company focu...
Japan headquartered Yokogawa Electric Corporation announces that it has acquired a nanopipette technology that was devel...
Novo Nordisk A/S and Japanese chemical company UBE Industries Ltd. recently announced that Novo Nordisk has obtained an ...
University of Texas MD Anderson Cancer Center (The University of Texas MD Anderson Cancer Center) and Takeda P...
Kayentis, a global provider of eCOA (electronic Clinical Outcome Assessment) solutions for clinical trials, has announce...
Fujitsu, on 7 Nov 2019, announced the results of a joint research project it has been conducting with the Institute of M...
